TORL BioTherapeutics
PrivateLast Round
Series C
Oct 7, 2025
Total Funding Raised
$461.9M
Company Overview
TORL BioTherapeutics is a biopharmaceutical company that develops antibody-drug conjugates and monoclonal antibodies for the treatment of various cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TORL BioTherapeutics Comparables
Compare TORL BioTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gilead Sciences | 87% | |
| Sutro Biopharma Inc | 80% | |
| Genmab A/S | 79% | |
TORL BioTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 7, 2025 | ||||
| Series B Extension | Apr 10, 2024 | ||||
| Series B | Apr 13, 2023 |
Key People
Founding team and executive leadership
TORL BioTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B Extension |
| Vertex Ventures HC | Series B, Series B Extension |
| Perceptive Advisors | Series B, Series B Extension |
| Xontogeny | Series B, Series B Extension |
| TD Securities | Series B |
| Blue Owl Capital | Series B, Series B Extension |
| Deep Track Capital | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2024
$158M round led by Deep Track Capital.
- Apr 13, 2023
$158M round led by Goldman Sachs Asset Management.
TORL BioTherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TORL BioTherapeutics's valuation, stock price, and market status.